Mobia Medical, Inc. develops and commercializes neurostimulation medical devices, including implantable systems for stroke rehabilitation and other neurological conditions. The company provides neurostimulation systems and devices that combine vagus nerve stimulation with therapy to address chronic neurological conditions. Its main product, the Vivistim System, is an FDA-approved implantable device designed to aid in the rehabilitation of upper limb motor function in post-stroke patients. The paired VNS platform is used to help patients relearn movements and improve motor deficits, and it is…
| Price | $10.86 |
|---|---|
| Market cap | $361.13M |
| Sector | Healthcare |
| Industry | Medical - Specialties |
| Exchange | NASDAQ |
| 52-week range | 9.85-15.29 |
| Beta | -0.59 |
Explore MOBI's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.